Asia Pacific Exosomes Market Size & Outlook, 2026-2033
- Biotechnology
- RNA analysis
- Exosomes Market Outlook
- RNA analysis
Global Market
Related Markets
Ask Prism AI anything about the exosomes market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Asia Pacific exosomes market highlights
- The Asia Pacific exosomes market generated a revenue of USD 29.1 million in 2024.
- The market is expected to grow at a CAGR of 26.4% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2024.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 29.1 million |
| Market revenue in 2030 | USD 116.6 million |
| Growth rate | 26.4% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 16.4% of the global exosomes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 476.3 million by 2030.
The region is expected to exhibit lucrative growth owing increase in awareness about innovative and novel technologies. Increase in focus on the development of healthcare infrastructure along with the demand for advanced diagnostics & efficient therapeutic solutions are among factors expected to positively influence growth.
Furthermore, emerging economies in the region are involved in establishing research facilities and infrastructure for the emerging biotechnology field. Human resource with the required skills is available on a large scale. Leading market players are involved in collaborations and partnerships to tap the growth potential in these regions.
For instance, in November 2013, Agilent Technologies, Inc. collaborated with Seoul National University Hospital for the development of biomarkers. Japan dominated the APAC market in 2018. High incidence of degenerative disorders owing to the presence of a large aging population and the rapid adoption of technologically advanced products are among significant factors contributing to the country largest market share.
No credit card required*
Publish Date: May 05, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | www.miltenyibiotec.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | roosterbio.com |
Asia Pacific Exosomes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 57.73% in 2024.
Horizon Databook has segmented the Asia Pacific exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The region is expected to exhibit lucrative growth owing increase in awareness about innovative and novel technologies. Increase in focus on the development of healthcare infrastructure along with the demand for advanced diagnostics & efficient therapeutic solutions are among factors expected to positively influence growth.
Furthermore, emerging economies in the region are involved in establishing research facilities and infrastructure for the emerging biotechnology field. Human resource with the required skills is available on a large scale. Leading market players are involved in collaborations and partnerships to tap the growth potential in these regions.
For instance, in November 2013, Agilent Technologies, Inc. collaborated with Seoul National University Hospital for the development of biomarkers. Japan dominated the APAC market in 2018. High incidence of degenerative disorders owing to the presence of a large aging population and the rapid adoption of technologically advanced products are among significant factors contributing to the country largest market share.
- Asia Pacific Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Isolation Methods
- Downstream Analysis
- Asia Pacific Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Kits & Reagents
- Instruments
- Services
- Asia Pacific Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & diagnostics centers
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Asia Pacific Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurodegenerative diseases
- Cardiovascular diseases
- Others
- Cancer
- Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
- Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Exosomes Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Exosomes Market, 2021-2033 (US$M)
Asia Pacific exosomes market statistics, by workflow, 2021-2033 (US$M)
